153 related articles for article (PubMed ID: 25659427)
21. Balance of antiangiogenic and angiogenic factors in the context of the etiology of preeclampsia.
Seki H
Acta Obstet Gynecol Scand; 2014 Oct; 93(10):959-64. PubMed ID: 25139038
[TBL] [Abstract][Full Text] [Related]
22. Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays.
Benton SJ; Hu Y; Xie F; Kupfer K; Lee SW; Magee LA; von Dadelszen P
Am J Obstet Gynecol; 2011 Nov; 205(5):469.e1-8. PubMed ID: 21903191
[TBL] [Abstract][Full Text] [Related]
23. [Pathophysiology of preeclampsia].
Schmidt M; Kimmig R
Gynakol Geburtshilfliche Rundsch; 2007; 47(4):199-204. PubMed ID: 17914264
[TBL] [Abstract][Full Text] [Related]
24. Examination of distinct fetal and maternal molecular pathways suggests a mechanism for the development of preeclampsia.
Goldman-Wohl DS; Yagel S
J Reprod Immunol; 2007 Dec; 76(1-2):54-60. PubMed ID: 17482678
[TBL] [Abstract][Full Text] [Related]
25. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
[TBL] [Abstract][Full Text] [Related]
26. Role of nitric oxide, angiogenic growth factors and biochemical analysis in preeclampsia.
Saha T; Halder M; Das A; Das SK
Indian J Biochem Biophys; 2013 Oct; 50(5):462-6. PubMed ID: 24772969
[TBL] [Abstract][Full Text] [Related]
27. Angiogenic factors in preeclampsia and related disorders.
Cerdeira AS; Karumanchi SA
Cold Spring Harb Perspect Med; 2012 Nov; 2(11):. PubMed ID: 23125198
[TBL] [Abstract][Full Text] [Related]
28. The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia.
Fisher SJ
Reprod Biol Endocrinol; 2004 Jul; 2():53. PubMed ID: 15236649
[TBL] [Abstract][Full Text] [Related]
29. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction.
Wallner W; Sengenberger R; Strick R; Strissel PL; Meurer B; Beckmann MW; Schlembach D
Clin Sci (Lond); 2007 Jan; 112(1):51-7. PubMed ID: 16928195
[TBL] [Abstract][Full Text] [Related]
30. Angiogenesis and placental growth in normal and compromised pregnancies.
Ong S; Lash G; Baker PN
Baillieres Best Pract Res Clin Obstet Gynaecol; 2000 Dec; 14(6):969-80. PubMed ID: 11141344
[TBL] [Abstract][Full Text] [Related]
31. Angiogenic factors and pre-eclampsia: an early marker is needed.
Stepan H
Clin Sci (Lond); 2009 Feb; 116(3):231-2. PubMed ID: 19032146
[TBL] [Abstract][Full Text] [Related]
32. The association of body mass index with serum angiogenic markers in normal and abnormal pregnancies.
Zera CA; Seely EW; Wilkins-Haug LE; Lim KH; Parry SI; McElrath TF
Am J Obstet Gynecol; 2014 Sep; 211(3):247.e1-7. PubMed ID: 24631439
[TBL] [Abstract][Full Text] [Related]
33. Investigating the role of angiogenesis in systemic lupus erythematosus.
Liu J; Wang X; Yang X; Yan Q; Wang S; Han W
Lupus; 2015 May; 24(6):621-7. PubMed ID: 25359881
[TBL] [Abstract][Full Text] [Related]
34. Levels of maternal serum angiogenic factors in third-trimester normal pregnancies: reference ranges, influence of maternal and pregnancy factors and fetoplacental Doppler indices.
Lobmaier SM; Figueras F; Mercade I; Crovetto F; Peguero A; Parra-Saavedra M; Ortiz JU; Crispi F; Gratacós E
Fetal Diagn Ther; 2014; 36(1):38-43. PubMed ID: 24903330
[TBL] [Abstract][Full Text] [Related]
35. Altered angiogenesis in preeclampsia: evaluation of a new test system for measuring placental growth factor.
Schmidt M; Dogan C; Birdir C; Callies R; Kuhn U; Gellhaus A; Janetzko A; Kimmig R; Kasimir-Bauer S
Clin Chem Lab Med; 2007; 45(11):1504-10. PubMed ID: 17970705
[TBL] [Abstract][Full Text] [Related]
36. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.
Sahay AS; Patil VV; Sundrani DP; Joshi AA; Wagh GN; Gupte SA; Joshi SR
Hypertens Res; 2014 Aug; 37(8):753-8. PubMed ID: 24718301
[TBL] [Abstract][Full Text] [Related]
37. Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia.
Unal ER; Robinson CJ; Johnson DD; Chang EY
Am J Obstet Gynecol; 2007 Aug; 197(2):211.e1-4. PubMed ID: 17689655
[TBL] [Abstract][Full Text] [Related]
38. Maternal and foetal angiogenic imbalance in congenital heart defects.
Llurba E; Sánchez O; Ferrer Q; Nicolaides KH; Ruíz A; Domínguez C; Sánchez-de-Toledo J; García-García B; Soro G; Arévalo S; Goya M; Suy A; Pérez-Hoyos S; Alijotas-Reig J; Carreras E; Cabero L
Eur Heart J; 2014 Mar; 35(11):701-7. PubMed ID: 24159191
[TBL] [Abstract][Full Text] [Related]
39. Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia.
Verlohren S; Stepan H; Dechend R
Clin Sci (Lond); 2012 Jan; 122(2):43-52. PubMed ID: 21929511
[TBL] [Abstract][Full Text] [Related]
40. Placental vascular pathology as a mechanism of disease in pregnancy complications.
Kovo M; Schreiber L; Bar J
Thromb Res; 2013 Jan; 131 Suppl 1():S18-21. PubMed ID: 23452733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
